Takeda India Strengthens Patient Offering via Availability of Vedolizumab

Introduces innovative Gastrointestinal portfolio for patients with Inflammatory Bowel Diseases (IBD) and Ulcerative Colitis and Crohn’s Disease. Takeda India, part of the Takeda Pharmaceutical Company Ltd., a global values-based…

Read More Takeda India Strengthens Patient Offering via Availability of Vedolizumab
Top